Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Table of Contents

July 01, 1996; Volume 278,Issue 1
  • You have access
    Characterization of endothelin-induced nociception in mice: evidence for a mechanistically distinct analgesic model.
    R B Raffa, J J Schupsky, D K Lee and H I Jacoby
    Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 1-7;
  • You have access
    Paracetamol exerts a spinal antinociceptive effect involving an indirect interaction with 5-hydroxytryptamine3 receptors: in vivo and in vitro evidence.
    T Pelissier, A Alloui, F Caussade, C Dubray, A Cloarec, J Lavarenne and A Eschalier
    Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 8-14;
  • You have access
    The sensitivity of N-methyl-D-aspartate receptors to lead inhibition is dependent on the receptor subunit composition.
    I A Omelchenko, C S Nelson, J L Marino and C N Allen
    Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 15-20;
  • You have access
    Identification of human cytochrome P450 isoforms involved in the stereoselective metabolism of mianserin enantiomers.
    E Koyama, K Chiba, M Tani and T Ishizaki
    Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 21-30;
  • You have access
    Stereospecificity in contraluminal and luminal transporters of organic cations in the rat renal proximal tubule.
    A A Somogyi, G Rumrich, G Fritzsch and K J Ullrich
    Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 31-36;
  • You have access
    Inhibition of type IV phosphodiesterase by Ro 20-1724 attenuates endotoxin-induced acute renal failure.
    D P Begany, J A Carcillo, W A Herzer, Z Mi and E K Jackson
    Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 37-41;
  • You have access
    Endothelin A receptor antagonism by PD 156707 does not reduce infarct size after coronary artery occlusion/reperfusion in pigs.
    T E Mertz, T B McClanahan, M A Flynn, P Juneau, E E Reynolds, H Hallak, L Bradford and K P Gallagher
    Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 42-49;
  • You have access
    Effects of drug discrimination history on the generalization of pentobarbital to other drugs.
    D E McMillan, W L Sun and W C Hardwick
    Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 50-61;
  • You have access
    Nonpeptide glycoprotein IIb/IIIa inhibitors. 8. Antiplatelet activity and oral antithrombotic efficacy of L-734,217.
    J J Cook, M A Holahan, E A Lyle, D R Ramjit, G R Sitko, M T Stranieri, R F Stupienski, A A Wallace, E L Hand, J R Gehret, T Kothstein, M D Drag, G Y McCormick, J J Perkins, N C Ihle, M E Duggan, G D Hartman, R J Gould and J J Lynch
    Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 62-73;
  • You have access
    Influence of feeding schedule on the chronopharmacological aspects of sodium valproate in mice.
    S Ohdo, N Ogawa, S Nakano and S Higuchi
    Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 74-81;
  • You have access
    Effect of S-21663 (PMS 812), an imidazoline derivative, on glucose tolerance and insulin secretion in a rat model of type II diabetes.
    X Wang, F Rondu, A Lamouri, R Dokhan, S Marc, E Touboul, B Pfeiffer, D Manechez, P Renard, B Guardiola-Lemaitre, J J Godfroid, A Ktorza and L Pénicaud
    Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 82-89;
  • You have access
    Involvement of spinal cholecystokininB receptors in mediating neurotensin hyperalgesia from the medullary nucleus raphe magnus in the rat.
    M O Urban, D J Smith and G F Gebhart
    Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 90-96;
  • You have access
    Intrathecal nicotinic agonist-elicited release of excitatory amino acids as measured by in vivo spinal microdialysis in rats.
    I M Khan, M Marsala, M P Printz, P Taylor and T L Yaksh
    Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 97-106;
  • You have access
    Poor permeability of morphine 3-glucuronide and morphine 6-glucuronide through the blood-brain barrier in the rat.
    U Bickel, O P Schumacher, Y S Kang and K Voigt
    Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 107-113;
  • You have access
    Evidence for a selective effect of ethanol on N-methyl-d-aspartate responses: ethanol affects a subtype of the ifenprodil-sensitive N-methyl-d-aspartate receptors.
    X Yang, H E Criswell, P Simson, S Moy and G R Breese
    Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 114-124;
  • You have access
    Involvement of alpha-2 adrenoceptors in the periaqueductal gray-induced inhibition of dorsal horn cell activity in rats.
    Y B Peng, Q Lin and W D Willis
    Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 125-135;
  • You have access
    Structure activity relationships of a series of buspirone analogs at alpha-1 adrenoceptors: further evidence that rat aorta alpha-1 adrenoceptors are of the alpha-1D-subtype.
    D L Saussy, A S Goetz, K L Queen, H K King, M W Lutz and T J Rimele
    Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 136-144;
  • You have access
    Modulation of [3H]quinpirole binding in brain by monoamine oxidase inhibitors: evidence for a potential novel binding site.
    B Levant, J D Moehlenkamp, K A Morgan, N L Leonard and C C Cheng
    Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 145-153;
  • You have access
    Comparison of bidisomide, flecainide and dofetilide on action potential duration in isolated canine atria: effect of isoproterenol.
    C L Martin, M A Palomo and E G Mcmahon
    Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 154-162;
  • You have access
    Cytotoxicity of hexachlorocyclohexane isomers and cyclodienes in primary cultures of cerebellar granule cells.
    R Rosa, E Rodriguez-Farré and C Sanfeliu
    Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 163-169;
  • You have access
    Electrophysiologic and proarrhythmogenic effects of therapeutic and toxic doses of imipramine: a study with high resolution ventricular epicardial mapping in rabbit hearts.
    E Robert, P Bruelle, J E de La Coussaye, J M Juan, J Brugada, P Peray, M Dauzat and J J Eledjam
    Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 170-178;
  • You have access
    Evaluation of detomidine-induced analgesia in horses with chronic hoof pain.
    J G Owens, S G Kamerling, S R Stanton and M L Keowen
    Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 179-184;
  • You have access
    The potential of a novel polyamine transport inhibitor in cancer chemotherapy.
    S M Aziz, M N Gillespie, P A Crooks, S F Tofiq, C P Tsuboi, J W Olson and M P Gosland
    Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 185-192;
  • You have access
    Nitric oxide modulates neuropeptide Y regulation of ion transport in mouse ileum.
    R K Rao, Y Lopez, P J Riviere, X Pascaud, J L Junien and F Porreca
    Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 193-198;
  • You have access
    Inhibitory transmission in guinea pig stomach mediated by distinct receptors for pituitary adenylate cyclase-activating peptide.
    S Katsoulis, W E Schmidt, R Schwarzhoff, U R Folsch, J G Jin, J R Grider and G M Makhlouf
    Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 199-204;
  • You have access
    The secretory intestinal transport of some beta-lactam antibiotics and anionic compounds: a mechanism contributing to poor oral absorption.
    H Saitoh, C Gerard and B J Aungst
    Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 205-211;
  • You have access
    Enhancement of morphine antinociception by a CCKB antagonist in mice is mediated via opioid delta receptors.
    T W Vanderah, R N Bernstein, H I Yamamura, V J Hruby and F Porreca
    Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 212-219;
  • You have access
    The effects of calcitonin gene-related peptide on the cytosolic calcium concentration and force in the porcine coronary artery.
    Y Fukuizumi, S Kobayashi, J Nishimura and H Kanaide
    Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 220-231;
  • You have access
    Systemic and regional hemodynamic and biological effects of a new kappa-opioid agonist, niravoline, in healthy volunteers.
    E Bellissant, T Denolle, P Sinnassamy, D G Bichet, J F Giudicelli, F Lecoz, J M Gandon and H Allain
    Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 232-242;
  • You have access
    E2011 a novel, selective and reversible inhibitor of monoamine oxidase type A.
    T Kagaya, A Kajiwara, S Nagato, K Akasaka and A Kubota
    Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 243-251;
  • You have access
    Recombinant human secretory phospholipase A2 released thromboxane from guinea pig bronchoalveolar lavage cells: in vitro and ex vivo evaluation of a novel secretory phospholipase A2 inhibitor.
    J H Fleisch, C T Armstrong, C R Roman, E D Mihelich, S M Spaethe, W T Jackson, J L Bobbitt, S Draheim, N J Bach, R D Dillard, M Martinelli, R Fouts and D W Snyder
    Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 252-257;
  • You have access
    Co-administration of MDMA with drugs that protect against MDMA neurotoxicity produces different effects on body temperature in the rat.
    J E Malberg, K E Sabol and L S Seiden
    Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 258-267;
  • You have access
    U46619 (a thromboxane A2 mimetic) induces airflow obstruction and airway plasma extravasation in the guinea pig: the role of histamine, cyclooxygenase metabolites, leukotrienes and PAF.
    I Kawikova, H Arakawa, B E Skoogh, C G Löfdahl and J Lötvall
    Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 268-276;
  • You have access
    Influence of renal failure in rats on the disposition of salicyl acyl glucuronide and covalent binding of salicylate to plasma proteins.
    J H Liu, R S Malone, H Stallings and P C Smith
    Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 277-283;
  • You have access
    Contrasting effects of anesthetics in tadpole bioassays.
    H Downes and P M Courogen
    Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 284-296;
  • You have access
    Inhibition of the slow pressor effect of angiotensin II contributes to the antihypertensive effect of angiotensin-converting enzyme inhibitors in renovascular hypertension.
    M G Melaragno and G D Fink
    Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 297-303;
  • You have access
    Antinociceptive action of 2-(4-bromobenzoyl)-3-methyl-4,6-dimethoxy benzofuran, a novel xanthoxyline derivative on chemical and thermal models of nociception in mice.
    Z R Vaz, V C Filho, R A Yunes and J B Calixto
    Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 304-312;
  • You have access
    Long-term exposure to ethanol increases the number and function of muscarinic M1 receptors in human neuroblastoma cells.
    C Larsson, P Simonsson, M Caron and C Alling
    Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 313-319;
  • You have access
    U-73122: a potent inhibitor of human polymorphonuclear neutrophil adhesion on biological surfaces and adhesion-related effector functions.
    R J Smith, J M Justen, A R McNab, C L Rosenbloom, A N Steele, P A Detmers, D C Anderson and A M Manning
    Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 320-329;
  • You have access
    Locomotor sensitization and decrease in [3H]mazindol binding to the dopamine transporter in the nucleus accumbens are delayed after chronic treatments by GBR12783 or cocaine.
    D Boulay, D Duterte-Boucher, I Leroux-Nicollet, L Naudon and J Costentin
    Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 330-337;
  • You have access
    Ethanol exposure alters the phosphorylation of cyclic AMP responsive element binding protein and cyclic AMP responsive element binding activity in rat cerebellum.
    X Yang, A M Diehl and G S Wand
    Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 338-346;
  • You have access
    Cocaine-induced sensitization of metabolic activity in extrapyramidal circuits involves prior dopamine D1-like receptor stimulation.
    W L Thomas, E S Cooke and R P Hammer
    Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 347-353;
  • You have access
    Dopamine D2L receptor couples to G alpha i2 and G alpha i3 but not G alpha i1, leading to the inhibition of adenylate cyclase in transfected cell lines.
    C M O'Hara, L Tang, R Taussig, R D Todd and K L O'Malley
    Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 354-360;
  • You have access
    Chronic nicotine and mecamylamine treatment increase brain nicotinic receptor binding without changing alpha 4 or beta 2 mRNA levels.
    J R Pauly, M J Marks, S F Robinson, J L van de Kamp and A C Collins
    Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 361-369;
  • You have access
    Inhibition of prostaglandin synthesis in newborn pigs increases cerebral microvessel prostaglandin F2 alpha and prostaglandin E2 receptors, their second messengers and vasoconstrictor response to adult levels.
    D Y Li, D Abran, K G Peri, D R Varma and S Chemtob
    Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 370-377;
  • You have access
    The thrombin inhibitor, hirudin, attenuates lipopolysaccharide-induced liver injury in the rat.
    J M Pearson, A E Schultze, K A Schwartz, M A Scott, J M Davis and R A Roth
    Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 378-383;
  • You have access
    Repeated intra-ventral tegmental area administration of SKF-38393 induces behavioral and neurochemical sensitization to a subsequent cocaine challenge.
    R C Pierce, B Born, M Adams and P W Kalivas
    Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 384-392;
  • You have access
    To what extent do spinal interactions between an alpha-2 adrenoceptor agonist and a mu opioid agonist influence noxiously evoked c-Fos expression in the rat? A pharmacological study.
    P Honoré, V Chapman, J Buritova and J M Besson
    Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 393-403;
  • You have access
    Chronic intrathecal infusion of phosphorothioate or phosphodiester antisense oligonucleotides against cytokine responsive gene-2/IP-10 in experimental allergic encephalomyelitis of lewis rat.
    W J Wojcik, P Swoveland, X Zhang and P Vanguri
    Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 404-410;
  • You have access
    Evidence for involvement of ventral tegmental area cyclic AMP systems in behavioral sensitization to psychostimulants.
    B K Tolliver, L B Ho, M S Reid and S P Berger
    Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 411-420;
  • You have access
    Enhanced release of interleukin-10 and soluble tumor necrosis factor receptors as novel principles of methylxanthine action in murine models of endotoxic shock.
    S Jilg, J Barsig, M Leist, S Küsters, H D Volk and A Wendel
    Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 421-431;
  • You have access
    Conformationally biased analogs of human C5a mediate changes in vascular permeability.
    R Kawatsu, S D Sanderson, I Blanco, N Kendall, A M Finch, S M Taylor and D Colcher
    Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 432-440;
  • You have access
    Frequent distribution of ultrarapid metabolizers of debrisoquine in an ethiopian population carrying duplicated and multiduplicated functional CYP2D6 alleles.
    E Aklillu, I Persson, L Bertilsson, I Johansson, F Rodrigues and M Ingelman-Sundberg
    Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 441-446;
  • You have access
    An antisense oligodeoxynucleotide to glyceraldehyde-3-phosphate dehydrogenase blocks age-induced apoptosis of mature cerebrocortical neurons in culture.
    R Ishitani, M Kimura, K Sunaga, N Katsube, M Tanaka and D M Chuang
    Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 447-454;
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 278, Issue 1
1 Jul 1996
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.
  • Functional Selectivity and Classical Concepts of Quantitative Pharmacology
  • Abl Protein-Tyrosine Kinase Inhibitor STI571 Inhibits In Vitro Signal Transduction Mediated by c-Kit and Platelet-Derived Growth Factor Receptors
  • The Prediction of Human Pharmacokinetic Parameters from Preclinical and In Vitro Metabolism Data
  • A METHOD FOR DETERMINING LOSS OF PAIN SENSATION
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics